(1) "First creation" + "first show" Import Expo highlights to see first -"A nuclear magnetic resonance system for infants and young children will be the flagship product of the company's participation in the import fair. This is the world's first and the first exhibition in Asia, which will greatly reduce the risk of MRI in infants and young children." Zhuang Xinyao, deputy director, said that at present, the hospital uses adult equipment for magnetic resonance testing of infants and children. The risk is relatively high and the detection images are not fine enough. In addition, the traditional nuclear magnetic system has a weight of five or six tons, the general ground can not bear, need to be reinforced, this system is about 2.5 tons, can be placed next to the neonatal intensive care unit, reducing the time and risk of patients on the way back and forth. The products have not yet been listed, and many hospitals have expressed their intention to purchase. Intelligentization is a major trend in medical devices. “Exhibition products will conform to the latest trends in medical technology. For example, there is only one coin-sized leadless pacemaker, which is about 90% smaller than traditional pacemakers, and the implantation method is different, which reduces the risk of infection and helps patients recover faster. Zhou Zuyi, director of corporate communications at Medtronic Greater China, said. The two divisions of the Roche Group's Diagnostics and Pharmaceuticals will be exhibiting for the first time, including cutting-edge technology for early research and development, the concept of “integration and treatment” covering the entire life cycle, and innovative solutions for individualized medicine. It is reported that the Roche Shanghai Innovation Center under construction has an investment of 863 million yuan and is expected to be completed in 2019. In the future, it will focus on research and early development of innovative drugs in the fields of immunity, inflammation and anti-infective diseases to meet China and even the whole. World patient needs. Fujifilm, which entered China in the 1980s, is also seeking new changes in the medical field. “For the first time, we brought all the products in the medical and health field to China, and fully demonstrated the corporate image after the transformation through the Import Expo.” Yao Jiafeng, vice president of Fujifilm (China) Investment Co., Ltd. said that this time will include the display for women. Products for early diagnosis of breast cancer, 3D medical network products, products combining artificial intelligence and traditional imaging technology.
(II) The big health industry has entered the “Golden Decade”. Nearly 120 exhibitors and businessmen from home and abroad have cooperated. Recently, the “First China International Import Expo Medical Device and Medical and Health Exhibition Area exhibitors and merchants exhibition before and after the supply and demand matchmaking meeting” was held at the National Convention and Exhibition Center ( Shanghai) held. Nearly 120 exhibitors from home and abroad launched exchanges and joint efforts to seek cooperation and development. Including Johnson & Johnson, Roche, Bayer, Merck, Royal Philips, Novartis, Sanofi, Medtronic, Siemens Medical, GE Healthcare and other signing exhibitors, as well as large-scale tertiary hospitals, private medical institutions, and provincial and municipal pharmaceutical chains nationwide. A group of buyers including retail and large pharmaceutical distribution companies. Sun Chenghai, deputy director of the China International Import and Export Expo, said that China's medical equipment and health industry have entered the "Golden Decade" and welcomes global companies to explore more business opportunities through the platform of the Import Expo. According to forecasts, by 2020 China's medical device market will exceed 770 billion yuan, and the size of the large health industry market will exceed 10 trillion yuan. "The preparatory work for the first China International Import Expo has entered the final stage of hard work. It is expected that the number of purchasers of exhibitors will reach 150,000. Now the registration is very active, and it has exceeded 150,000." Sun Chenghai said. Zhu Haijun, vice president of the Public Affairs Department of Philips Greater China Group, told reporters that he is very confident in the future development of the Chinese market and attaches great importance to it. On the one hand, compared with other industries, medical care is a sunrise industry and is not affected by the economic cycle. On the other hand, China is the fastest growing region in the global market of Philips and the second largest market outside the United States. The exhibition area is 600 square meters, and I hope to explore more business opportunities and contribute to its global market. Song Chao, Marketing Manager of Omron Health Medical (China) Co., Ltd. Network Planning Department, said that the development of the Chinese market is very good, driving the performance of the entire group to increase. In the past, Omron, which is well known, may focus on older products such as “Three Highs”, and now the company is also exploring other fields. For example, a low-frequency massage device specifically for women's physiological pain is expected to be released in China at the end of this year or early next year, and the healthy consumer market is expected to perform. In addition, the import fair also gave the company an opportunity to explore how products can sink better in third- and fourth-tier cities. The reporter also learned at the matchmaking meeting that Germany's Artem Group, Dräger, Siemens Medical, Japan Fujifilm, Upstream Co., Ltd., and Ever Forget Medical Group signed a contract to register for the 2019 China International Import Expo. (transferred from: Eastern Fortune Network)